Search clinical trials for: Transferrin Receptor-Targeted Liposomal p53 cDNA

Total 2 results

Northwestern University
National Cancer Institute (NCI)

Withdrawn

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Breast Inflammatory Carcinoma

United States
University Hospital, Grenoble

Unknown

Targeted PCR and Acute Endophthalmitis (Targeted PCR)

Acute Endophthalmitis Post-operative

France

3

Subscribe